Evidence record
Lead Testing for Children Enrolled in Medicaid
- Jurisdiction
- Washington
- Publishing agency
- Office of the Washington State Auditor
- Publication date
- December 12, 2023
- Source record
- Original document linked
Findings
3
Recommendations
4
Overall conclusion
Washington State has not ensured adequate lead testing for children enrolled in Medicaid, despite the known risks and federal requirements. Testing rates are low and variable, especially among high-risk populations, indicating a need for improved monitoring, guidance, and outreach efforts to protect children's health.
Scope
The audit examined the extent of lead testing among children enrolled in Medicaid in Washington State from 2015 to 2022, focusing on testing rates at recommended ages, demographic and community risk factors, and the effectiveness of state efforts to promote testing.
Findings (3)
Each finding has a stable link.
- F-172
Only 26% of Medicaid-enrolled children received at least one lead test between ages 1 and 6, with only 3% tested at both recommended ages (12 and 24 months).
- F-173
Testing rates vary significantly by county and demographic factors, with higher rates among non-English speaking families and lower rates among tribal children.
- F-174
Most children at high risk for lead exposure, based on community risk factors, have not been tested, with about 75% not tested at all in high-risk communities.
Recommendations (4)
- R-198
Implement a monitoring process to identify children who have not received blood lead tests.
Related finding F-172 - R-199
Create clear and consistent guidance for healthcare providers regarding testing requirements.
Related finding F-173 - R-200
Enhance data sharing and performance measures to better track and increase testing compliance.
Related finding F-173 - R-201
Increase provider awareness and community outreach to improve testing rates.
Related finding F-174